The impact of BDNF on the cognitive functions of ultra-high risk patients: An exploratory study

Alexandre Couturier (1, 2) , Boris Chaumette (1, 3, 4) , Oussama Kebir (1, 3) , Anton Iftimovici (1, 3) , Emma Krebs (1) , Qin He (1) , Chuan Jiao (1) , Marie-Odile Krebs (1, 3) , Linda Scoriels (1, 3) , Ariel Frajerman (1, 5, 6)

1 IPNP - U1266 Inserm - Institut de psychiatrie et neurosciences de Paris
2 GHU AP-HP Nord - Université Paris Cité
3 GHU Paris Psychiatrie et Neurosciences
4 McGill University = Université McGill [Montréal, Canada]
5 CESP - Centre de recherche en épidémiologie et santé des populations
6 Hôpital Bicêtre [AP-HP, Le Kremlin-Bicêtre]

No abstract available

Domaines: Médecine humaine et pathologie

Alexandre Couturier, Boris Chaumette, Oussama Kebir, Anton Iftimovici, Emma Krebs, et al.. The impact of BDNF on the cognitive functions of ultra-high risk patients: An exploratory study. Schizophrenia Research, 2022, 262, pp.211-213. ⟨10.1016/j.schres.2022.11.016⟩. ⟨inserm-04172013⟩